Neuritic regeneration and synaptic reconstruction induced by withanolide A

Journal: British Journal of Pharmacology Authors: Tomoharu Kuboyama, Chihiro Tohda, Katsuko Komatsu PMID: 15711595 | PMCID: PMC1576076 | DOI: 10.1038/sj.bjp.0706122

Jul 28, 2026 | 1 min read

Research Gist

This preclinical study examined whether withanolide A, a compound isolated from ashwagandha root, could help rebuild damaged neuronal connections. In cultured cortical neurons injured using an amyloid-beta fragment, withanolide A promoted the regrowth of both axons and dendrites and supported the reconstruction of pre- and postsynaptic structures.

In an amyloid-beta-induced mouse model of memory impairment, oral treatment also improved spatial-memory performance and restored neuronal and synaptic markers in parts of the cortex and hippocampus. These findings provide early experimental evidence of neuronal repair potential, but they do not establish effectiveness in humans.

Key Learnings

  • The study tested isolated withanolide A, not whole ashwagandha root extract.
  • In damaged cultured cortical neurons, 1 µM withanolide A promoted regrowth of axons and dendrites.
  • The treatment also increased markers associated with the reconstruction of presynaptic and postsynaptic connections.
  • In memory-impaired mice, oral withanolide A at 10 µmol/kg/day for 13 days improved spatial-memory performance.
  • Neuronal and synaptic losses in the cerebral cortex and hippocampus were substantially restored in the animal model.
  • The experiments were conducted in cultured neurons and mice using an amyloid-beta 25–35 injury model, not in people with Alzheimer’s disease.
  • The paper does not provide clinical safety, tolerability or efficacy evidence for human supplementation.
Research Summary